《新股表現》心瑋醫療(06609.HK)暗盤低開5.8%報161元
根據輝立交易平台顯示,明天掛牌的上海心瑋醫療科技-B(06609.HK)暗盤低開5.8%報161元欠承接,最低暫見140元,現報146.5元,較上市價171元,低14%,成交1.2萬股。
心瑋是內地一家創新型神經介入醫療器械公司,公司兩款核心產品分別為CaptorTM取栓器械(「Captor」)及左心耳封堵器,Captor是為急性缺血性腦卒中而設,並已在中國商業化。
公司是次在港上市共發售約660.2萬股H股,並已引入清池資本及博裕資本等10名基石投資者,合共認購約300萬股;其中10%公開發售獲332倍超購,已啟動回撥機制佔比增至50%,認購一手中籤率10%,股份以招股範圍(160-171元)上限定價,料集資淨額約10.15億元,主要用作分配至公司核心產品與管線內其他在研產品、透過內部研究提升研發能力及持續擴充產品組合提供資金等。上市聯席保薦人分別為高盛及中金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.